The role of apolipoprotein E genetic variants in lipoprotein disorders
- 1 June 1992
- journal article
- review article
- Published by Wiley in Journal of Internal Medicine
- Vol. 231 (6) , 653-659
- https://doi.org/10.1111/j.1365-2796.1992.tb01254.x
Abstract
Apolipoprotein E plays a central role in lipoprotein metabolism by serving as a ligand for the binding of lipoproteins to lipoprotein receptors. Both common and rare variants of apoE have been described. The common variants apoE2 and apoE4 have a significant impact on interindividual variation of lipid and lipoprotein levels in normal subjects. The common variant apoE2 and more than half a dozen rare variants are defective in binding to the low‐density lipoprotein (LDL) receptor, and all are causally associated with the lipid disorder type III hyperlipoproteinaemia (HLP). The mode of inheritance of the disorder can be either dominant or recessive, depending on the particular mutation(s) in apoE, although the mechanisms involved are not fully understood. The common variant apoE4 and other rare variants have been reported to be associated with a variety of other lipoprotein disorders, but a causal link has not been established.Keywords
This publication has 65 references indexed in Scilit:
- Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree.Journal of Clinical Investigation, 1991
- Enhanced binding activity of an apolipoprotein E mutant, apo E5, to LDL receptors on human fibroblastsBiochemical and Biophysical Research Communications, 1990
- Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemiaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant.Journal of Clinical Investigation, 1989
- Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia.Journal of Clinical Investigation, 1987
- Familial apolipoprotein E deficiency.Journal of Clinical Investigation, 1986
- New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.Journal of Clinical Investigation, 1984
- Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.Journal of Clinical Investigation, 1983
- Lipoprotein receptors and cholesterol homeostasisBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1983
- Familial hyperlipoproteinemia type III: Deficiency of a specific apolipoprotein (APO E‐III) in the very‐low‐density lipoproteinsFEBS Letters, 1975